Clinical Trial Update: Anti-PD-1/PD-L1 Antibodies Plus Anti-VEGF Antibody Treatment in Patients With Advanced-Stage HCC

View source ↗

Summary

Clinical trial update describing a study of combining anti-PD-1/PD-L1 antibody therapy with an anti-VEGF antibody in patients with advanced hepatocellular carci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• PD-1/PD-L1 antibody
• VEGF antibody

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Hepatocellular Carcinoma | Status: RECRUITING